Physician profile
Jeffrey Mccarter
NPI 1841386562
$23,023.29
in general payments reported to CMS, 2019-2025
44 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $167 · 2021: $443 · 2022: $21K · 2023: $385 · 2024: $278 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,112.50 | 2019-2023 | |
| Smith+Nephew, INC. | $157.09 | 2019-2024 | Pico |
| Avita Medical Americas, LLC | $149.81 | 2025 | Permeaderm, Cohealyx, Recell |
| Sanara Medtech INC. | $143.42 | 2021 | |
| Hologic Sales and Service, LLC | $142.08 | 2022-2024 | Biozorb, Trunode, Localizer |
| Boston Scientific Corporation | $107.88 | 2021-2025 | Varithena Administration Pack, Spyglass Discover |
| Davol INC. | $104.80 | 2022-2025 | Phasix Mesh |
| Stryker Corporation | $73.71 | 2020-2022 | |
| Medtronic Vascular, INC. | $65.41 | 2019-2020 | |
| Merit Medical Systems INC | $62.68 | 2021-2025 | Savi Scout |
| Merck Sharp & Dohme LLC | $60.92 | 2019-2023 | Lynparza, Keytruda |
| Medtronic, INC. | $60.15 | 2021-2024 | Endurant Iis |
| Becton, Dickinson and Company | $53.34 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $48.57 | 2024-2025 | |
| Ethicon US, LLC | $46.63 | 2019-2023 | Echelon Flex |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $46.46 | 2019-2022 | |
| Innocoll Pharmaceuticals Limited | $34.62 | 2022 | |
| Aroa Biosurgery Incorporated | $32.55 | 2020-2024 | |
| Braintree Laboratories, INC. | $32.18 | 2022 | |
| Convatec INC. | $31.78 | 2023 | |
| Innovation Technologies INC | $31.51 | 2025 | Irrisept |
| Progenacare Global, LLC | $28.90 | 2023 | |
| W. L. Gore & Associates, INC. | $28.10 | 2024 | Gore Synecor Biomaterial |
| Surmodics, INC. | $27.87 | 2023-2025 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Endomagnetics LTD | $25.02 | 2022 | |
| Covidien LP | $24.63 | 2020 | |
| Exact Sciences Corporation | $24.53 | 2023 | |
| Halozyme INC | $21.23 | 2023 | |
| Portola Pharmaceuticals, LLC | $20.44 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.19 | 2023 | Exparel |
| Lifenet Health | $17.83 | 2024 | Theragenesis Wound Matrix |
| Leica Microsystems INC. | $16.19 | 2023 | Neoprobe |
| Bolton Medical INC | $16.18 | 2024 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Kci USA, INC. | $16.16 | 2021 | |
| Cagent Vascular INC | $15.81 | 2025 | Serrantor |
| Cashflow Solutions, LLC | $15.72 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Tela Bio, INC. | $15.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.94 | 2023 | Seglentis |
| Biocompatibles, INC. | $14.69 | 2019 | |
| Teleflex LLC | $14.66 | 2024 | Deknatel |
| Mallinckrodt Hospital Products INC. | $14.15 | 2021 | |
| Allergan, INC. | $13.97 | 2020 | |
| Bard Peripheral Vascular, INC. | $13.57 | 2022 | |
| Thd America, INC. | $6.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Mccarter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.